바이보스 테라퓨틱스 (VVOS) 주가

바이보스 테라퓨틱스(VVOS)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.16 (-6.36%), 시가총액 $0.01B, 52주 최저~최고 $0.58 ~ $6.95.

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was

핵심 지표

• 현재가: $0.16 (-6.36%)
• 시가총액: $0.01B
• 52주 최저~최고: $0.58 ~ $6.95
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

바이보스 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

바이보스 테라퓨틱스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 6.86
• 순이익률: -1.21%
• 영업이익률: -1.67%

자주 묻는 질문